One-off aesthetic appointments produce isolated results. Structured 12-week treatment stacking — backed by peer-reviewed research published in Aesthetic Surgery Journal — creates compounding clinical outcomes, dramatically higher patient satisfaction, and long-term adherence that transforms your practice revenue.
A retrospective single-center study evaluating the long-term efficacy, safety, tolerability, and patient adherence to a structured Stackable Treatment topical routine of four complementary formulations over a minimum of one year — applied concurrently with a wide range of in-office surgical and nonsurgical aesthetic procedures.
Authors: Sydney Pryor, Alec Semersky, Tiffany Sabev, Julius Few. Published in Aesthetic Surgery Journal Open Forum, June 2024.
Aesthet Surg J Open Forum. 2024 Jun 5;6:ojae037. doi: 10.1093/asjof/ojae037 · PMCID: PMC11150041 · Read Full Study →
For over a decade, the concept of "stacking" — combining multiple nonsurgical therapies in a single or structured multi-session setting — has been recognized in aesthetic medicine as the approach that produces results approximating surgical outcomes without surgical intervention. First formalized by lead author Dr. Julius Few in 2012, this approach combines modalities such as absorbable suture suspension, energy-based therapies (microfocused ultrasound and laser), neuromodulators, fillers, and fat transfer to address multiple signs of aging simultaneously.
The 2024 study extends this principle to topical and structured treatment routines — demonstrating that the same stacking logic that works for in-office procedures applies to comprehensive, multi-product client treatment pathways. When treatments are layered intentionally, in structured cycles, with complementary formulations addressing multiple aging mechanisms, outcomes are not just additive — they are compounding.
This is the clinical foundation of Renewal Pathways OS℠'s 12-week treatment stacking architecture: not one-off appointments, but structured journeys designed to allow each treatment layer to build on the last — producing progressive results that a single session never could.
Median age 62. All Fitzpatrick types II–VI represented. 100% received both surgical and nonsurgical in-office treatments during the study period — making this the most ecologically valid long-term stacking study published to date.
The range was 374–967 days, with an average of 606 days — over 20 months. This is the first study to review both long-term efficacy and tolerability of a multi-topical routine across multiple years of concurrent in-office procedures.
Published in Aesthetic Surgery Journal Open Forum (Oxford University Press, NLM-indexed). No adverse reactions reported. 100% of patients continued product use after study conclusion.
"The stacking of nonsurgical therapies effectively addresses multiple signs of aging… through different modalities. The effectiveness of stacking nonsurgical therapies is well established — however, the same stackable approach has not been thoroughly described in the literature for topical skin treatments."Pryor, Semersky, Sabev, Few · Aesthetic Surgery Journal Open Forum · 2024 · PMC11150041
Across every measurable skin parameter where patients presented with a concern, the structured Stackable Treatment protocol delivered improvement — with zero adverse reactions across the entire cohort.
Based on 14-patient cohort · PMC11150041 Table 3
Skin aging is driven by both intrinsic and extrinsic mechanisms simultaneously. Single-modality treatment addresses one pathway. Structured stacking addresses all of them — in the correct sequence, at the correct intervals.
ROS and oxidative stress are identified in the study as accelerating all visible aging processes — dyspigmentation, elasticity loss, texture degradation, and fine lines. Stacked antioxidant delivery (green tea EGCG, botanical oils) across a 12-week cycle provides cumulative ROS neutralization that no single-session treatment can sustain.
PMC11150041 · BackgroundRetinol strengthens the epidermis by promoting keratinocyte proliferation and increasing collagen production. However, retinol alone carries significant irritation risk that reduces compliance. Structured stacking with complementary barrier-protecting formulations eliminates this barrier — the study recorded zero irritation even at 1% retinol concentration.
PMC11150041 · DiscussionUp to 80% of extrinsic aging is UV-driven. Consistent mineral zinc oxide SPF 30 application, layered with occlusive and humectant moisturizers, preserves stratum corneum integrity and prevents transepidermal water loss — effects that accumulate meaningfully only across multiple weeks of structured routine adherence.
PMC11150041 · MethodsRetinol-driven skin cell turnover increases dead cell accumulation on the skin's surface, which actively blocks absorption of subsequent topicals. Glycolic acid exfoliation — applied on schedule within a stacked routine — clears this barrier, ensuring each subsequent treatment layer absorbs at maximum efficacy. This is a mechanism that only functions across a sustained cycle.
PMC11150041 · DiscussionIndividual active ingredients (retinol, glycolic acid, in-office peels, energy-based treatments) each carry individual irritation potential. When stacked with anti-inflammatory botanical ingredients — babassu oil, sunflower seed oil, olive oil, EGCG — the net inflammatory load decreases rather than compounds. This is why the study recorded zero adverse reactions despite patients receiving simultaneous surgical and nonsurgical procedures.
PMC11150041 · DiscussionThe study explicitly identifies non-compliance as a primary driver of poor skincare outcomes. Stacked routines with low irritation potential and structured application sequences demonstrate dramatically higher adherence — the study found 100% of patients continued product use post-conclusion. Structured 12-week pathways solve the compliance problem that makes single-session treatments fail to deliver lasting results.
PMC11150041 · IntroductionStructured progression — not random touchpoints. Each phase of the 12-week cycle addresses a distinct biological window, allowing compounding outcomes that single-session appointments structurally cannot produce.
The first three weeks allow the skin's barrier function to stabilize under consistent exfoliation, moisturization, and SPF. Dead cell accumulation from pre-existing neglect or prior irritating products is cleared. The client's treatment baseline is established. Intake consultation and pathway enrollment occur. Communication flows are active.
Science basis: Glycolic acid exfoliation clears keratinocyte accumulation; barrier preservation via occlusive/humectant layering begins improving transepidermal water loss metrics within 2–3 weeks of consistent application.Retinol-driven keratinocyte proliferation enters its active phase. With barrier function now stable and anti-inflammatory botanicals providing protective cover, higher retinol concentrations become tolerable — and collagen synthesis signaling is established. The Week 6 Journey Check-In™ captures mid-pathway engagement signals and client feedback, enabling real-time pathway adjustments.
Science basis: Retinol collagen stimulation requires a minimum of 4–6 weeks of consistent application to show measurable structural change. Compliance is the variable — structured pathways solve it.By week 7, cumulative ROS reduction and retinol activity begin producing visible improvements in surface texture, hydration, and pigmentation. In the study cohort, 92.9% of patients showed pigmentation improvement — a result requiring sustained antioxidant and retinol cycling, not one-off treatment. Clients in structured pathways are primed to recognize and document progress at this stage.
Science basis: Pigmentation and vasculature improvements require sustained antioxidant delivery (EGCG, botanical oils) over multiple weeks to modulate melanogenesis pathways and reduce UV-induced chromophore deposition.The 12-week mark is when transformation is measurable, photographable, and emotionally resonant for clients. Journey completion activates the natural re-enrollment conversation — not as a sales push, but as a structural transition into the next seasonal cycle. In the study, 100% of patients continued treatment post-study conclusion, demonstrating that structured pathways produce compliance that outlasts the study itself.
Science basis: The study's average follow-up of 606 days — well beyond the minimum 12-week cycle — indicates that structured treatment cycles produce lasting behavioral adherence, not just short-term results.Five key findings from the PMC11150041 Stackable Treatments study — and their direct implications for why 12-week structured pathways outperform one-off aesthetic appointments at every measurable level.
of study patients received nonsurgical treatment during the study period. Two (12.5%) received surgical treatment. Zero reported additional irritation from the combined approach.
This is perhaps the most operationally significant finding in the study. Stacked structured protocols do not conflict with in-office treatments — they enhance them by providing consistent baseline barrier function, anti-inflammatory cover, and exfoliation between sessions. The combined approach produced zero adverse reactions even in patients undergoing dermaplaning, Hydrafacial, HALO laser, Ulthera, Dysport, fillers, chemical peels, and facelift surgery concurrently.
For practices using Renewal Pathways OS℠: structured 12-week cycles complement every in-office treatment your practitioners deliver — making each session land on better-prepared, better-protected skin.
of patients continued using individual Stackable Treatment products after the study concluded — with retinol at 100%, combination moisturizer at 92.9%, glycolic cleanser at 78.6%, and physical SPF at 75%.
The study explicitly names inconsistent compliance as the primary barrier to skincare outcomes — pointing to irritation, over-complex routines, and lack of structured sequence as the drivers of non-adherence. The Stackable Treatment protocol solved this by using formulations specifically designed to work together, in a defined sequence, with low irritation potential.
Renewal Pathways OS℠'s 12-week treatment pathways are built on this same principle: structured simplicity drives completion. When clients know their pathway, when communication is automated and timely, and when each step is clearly defined — compliance becomes the norm, not the exception.
One of retinol's primary clinical limitations is irritation-driven non-compliance — redness, peeling, and sun sensitivity that causes patients to abandon treatment before results develop. This is typically more pronounced when retinol is layered with other active ingredients.
The study found zero irritation even at 1% retinol concentration — the highest strength used in the cohort. The researchers attribute this to the protective anti-inflammatory and antioxidant properties of the surrounding formulations in the stack: the combination moisturizer neutralizing ROS vulnerability created by retinol's mechanism; the sunscreen preventing UV-triggered retinol-sensitized damage; and the glycolic cleanser optimizing absorption so retinol concentration can remain controlled.
This is the structural argument for 12-week stacking over isolated treatment: when the surrounding protocol is designed to protect against each active ingredient's weakness, the entire stack becomes more effective than any single element could be alone.
Skin aging is multicausal. Intrinsic factors — collagen loss, keratinocyte decline, genetic predisposition — follow a different biological timeline than extrinsic factors — UV damage, environmental pollutants, ROS accumulation. Most single-treatment or single-modality approaches target one mechanism while leaving others unaddressed.
The Stackable Treatment study demonstrated improvements across six distinct skin parameters simultaneously: roughness, dehydration, scar appearance, visible pores, pigmentation, and vasculature. This breadth of improvement in a single cohort, with a single structured protocol, is direct evidence that stacking addresses aging comprehensively in a way that mono-therapy structurally cannot.
separate skin quality parameters improved simultaneously — without one treatment compromising another. No adverse tradeoffs.
The study authors explicitly note that this is the first published assessment of both long-term efficacy and tolerability of a multi-topical routine over multiple years — while concurrently tracking patients undergoing in-office aesthetic rejuvenation procedures.
This matters for practices considering structured treatment pathways: the evidence base for 12-week stacking cycles is not theoretical. It is peer-reviewed, NLM-indexed, multi-year longitudinal data showing that structured protocols produce compounding results over time — not diminishing returns from repeated isolated sessions.
The study's authors recommend future prospective, controlled study with larger and more diverse cohorts — meaning this is a growing evidence base. Practices that build structured stacking pathways now are aligning with the direction of clinical evidence, not against it.
The stacking framework for in-office nonsurgical therapies was introduced by Dr. Julius Few in 2012 — combining absorbable suture suspension with energy-based therapies, neuromodulators, fillers, and fat transfer to approach surgical outcomes without surgery. Over the following decade it became a common approach in advanced aesthetic practice.
The 2024 PMC11150041 study extends this logic to the structured between-session care environment — validating what practitioners have observed clinically: results compound when every layer of the client's experience is designed to work together.
Renewal Pathways OS℠ operationalizes this principle at the practice level. Every 12-week pathway is a structured stacking cycle — in-office treatments, at-home protocols, client communication, and seasonal re-enrollment, all coordinated to produce outcomes that one-off appointments simply cannot replicate.
Side by side: what the clinical evidence, adherence data, and outcome research tells us about each approach — and why the transition from transaction to structured journey is not just good business, it is the medically sound approach.
| Dimension | One-Off Appointments | 12-Week Structured Stacking |
|---|---|---|
| Mechanism Coverage | Single modality per visit — addresses one aging mechanism at a time | Multiple mechanisms addressed simultaneously across the cycle — intrinsic and extrinsic aging pathways both targeted |
| Retinol Tolerance | Irritation risk limits effective concentration; patients frequently abandon treatment before results develop | Zero irritation at 1% retinol in structured stack — anti-inflammatory and barrier-protective co-formulations eliminate compliance barriers |
| Result Compounding | Each session starts from baseline — results do not carry forward predictably | Each phase builds on the last — visible texture, hydration, and pigmentation improvements compound week over week |
| Patient Adherence | Compliance is inconsistent; patients return when they remember or experience a concern | 100% continued product use post-study; structured pathway communication maintains engagement between sessions |
| In-Office Synergy | Between-session protocols are optional or self-directed — quality and compliance highly variable | Structured at-home protocols complement every in-office modality; zero adverse reactions in combined approach (PMC11150041) |
| Revenue Predictability | Transaction-by-transaction revenue — each month starts from zero | Seasonal enrollment cycles create predictable recurring revenue that compounds with each re-enrollment |
| Clinical Evidence | Extensive per-modality evidence; structured multi-session stacking studied separately | Direct peer-reviewed evidence (PMC11150041) showing multi-year, multi-parameter improvement with zero adverse events in concurrent surgical/nonsurgical context |
| Skin Parameter Breadth | Typically 1–2 parameters per session per modality | 6 simultaneous parameters improved (roughness, dehydration, scars, pores, pigmentation, vasculature) — all without adverse tradeoffs |
The Stackable Treatment protocol is structured around four complementary formulation layers, each addressing a distinct aging mechanism — and each designed to enhance rather than interfere with the others. This is the functional model that Renewal Pathways OS℠ operationalizes at scale.
12-week treatment stacking is not a marketing concept — it is the clinically validated approach to aesthetic outcomes. Renewal Pathways OS℠ takes this evidence and builds it into structured seasonal pathways that run inside your practice, automatically, across every client journey.
Live in 3–5 days. No tools replaced. Spring Class of 2026 is now open — 25 founding partner spots remain.
Apply code SPRING26 at checkout for 50% off your implementation investment. Limited to the first 25 founding partners.